Biorestorative Therapies - 53 Year Dividend History | BRTX

Historical dividend payout and yield for Biorestorative Therapies (BRTX) since 1971. The current TTM dividend payout for Biorestorative Therapies (BRTX) as of May 22, 2024 is $0.00. The current dividend yield for Biorestorative Therapies as of May 22, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.009B $0.000B
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells. The company's core programs consist of Disc/Spine Program and Metabolic Program. Disc/Spine Program consists of cell therapy candidate, brtxDISC(TM) is a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow. Metabolic Program consists of ThermoStem(R), developing an allogeneic cell-based therapy to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. BioRestorative Therapies, Inc. is based in Melville, New York.
Stock Name Country Market Cap PE Ratio